Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.12 USD | +0.31% | +0.57% | -12.01% |
May. 20 | Exelixis Settles Cabometyx Patent Litigation with Cipla | MT |
May. 14 | Transcript : Exelixis, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 02:35 PM |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.01% | 6.13B | |
+8.05% | 115B | |
+13.09% | 107B | |
-12.91% | 22.31B | |
-3.99% | 21.6B | |
-6.20% | 18.23B | |
-39.93% | 17.62B | |
+6.98% | 14.26B | |
+32.66% | 12.37B | |
-28.57% | 8.28B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Transcript : Exelixis, Inc. Presents at Leerink Partners Global Biopharma Conference 2024, Mar-12-2024 09